25.09.2012
- Market Overview - With the euro crisis biting ever harder, the US economy still staggering under a formidable debt burden and even the Chinese growth engine sputtering, the chief...
20.09.2012
- Pressure from governments to lower drug prices risks undermining medical innovation, Bayer's chief executive Marjin Dekkers said on Wednesday, echoing complaints of other drug...
02.09.2012
- Leaving the euro zone could help Greece to recover economically and prevent the region's debt crisis from spreading, the head of German drugmaker Bayer was quoted as saying in a...
23.03.2012
- The Bayer Group sees good perspectives for its businesses in the medium term. "In the life science areas - HealthCare and CropScience - we anticipate further increases in sales and...
29.02.2012
- German chemicals and drugs group Bayer posted a 9% drop in fourth-quarter profit as price rises failed to offset soaring oil-derived raw materials costs at its plastics division...
21.03.2011
- Bayer's Chief Executive Marijn Dekkers came with M&A credentials from his previous job last year and investors have been looking for clues where he plans to take the 147 year-old...
23.02.2011
- Germany's Bayer could use its MaterialScience unit as "currency" should the company decide to pursue a large acquisition, its chief executive told the Financial Times. The unit...
29.09.2010
- Bayer could spend around €17 billion of its war chest for acquisitions to boost its healthcare and seeds businesses, its incoming chief executive said just days before taking the...
